An article highlights the stigma, rejection, and failed relationships experienced by women living with Polycystic Ovary Syndrome (PCOS), with experts warning that ignorance and poor awareness fuel discrimination and delayed diagnosis.
The medical community has announced that Polycystic Ovary Syndrome (PCOS) will be officially renamed to Polyendocrine Metabolic Ovary Syndrome (PMOS) starting May 12, 2026, following a decision at the European Congress of Endocrinology.
Polycystic Ovary Syndrome (PCOS) presents with varied symptoms such as pain, cysts, irregular cycles, acne, and difficulty conceiving. The condition remains poorly understood, leading to diagnostic uncertainty and delays for many women.
A former contestant on the Great British Bake Off has revealed that her polycystic ovary syndrome (PCOS) played a significant role in her journey to culinary fame. She shared how the condition influenced her path and ultimately contributed to her success on the show.
Health experts in Jersey support a proposed name change for Polycystic Ovary Syndrome (PCOS), stating it would better represent the condition as it is not solely an ovaries-only issue.
Polycystic Ovary Syndrome (PCOS) has been renamed to Polycystic Ovarian Syndrome (PMOS), a change highlighted as an important step. The endocrine disorder affects one in eight women, impacting not only fertility but the entire system.
An article explores the reasons why renaming Polycystic Ovary Syndrome (PCOS) to Polycystic Metabolic Ovarian Syndrome (PMOS) is considered more significant than commonly perceived, highlighting the implications of such a change.
Discussions are underway to change the name of Polycystic Ovary Syndrome (PCOS), a condition affecting approximately 1 in 8 women globally with a wide range of symptoms.
Polycystic Ovary Syndrome (PCOS) has been renamed as part of a broader effort by doctors to rethink women's healthcare. Medical professionals, including those in the UAE, have explained that the change was necessary due to previous mischaracterizations and to better reflect the condition.
Women's health experts have proposed renaming Polycystic Ovary Syndrome (PCOS) to Polyendocrine Metabolic Ovarian Syndrome (PMOS) in a landmark paper, hoping the new name will improve diagnosis and treatment for the condition affecting one in eight women globally.
Women's health experts have proposed renaming Polycystic Ovary Syndrome (PCOS) to Polyendocrine Metabolic Ovarian Syndrome (PMOS) in a landmark paper published in The Lancet medical journal, warning that the current name could be misleading patients.
Polycystic ovary syndrome is being relabelled polyendocrine metabolic ovarian syndrome to correct the misconception that it is solely a gynaecological disease that creates ovarian cysts. Here’s what you need to know about the condition
• ‘Unprecedented’ global effort gives new name to polycystic ovary syndrome – and new hope to millions of women
• ‘I still want to scream’: the loneliness and confusion of living with PMOS
With polycystic ovary syndrome (PCOS) now being rebadged as polyendocrin...
A woman who experienced severe PMS and was later diagnosed with polycystic ovary syndrome developed an app to help other women manage similar struggles.
The article discusses Polycystic Ovary Syndrome (PCOS) and Polycystic Menstrual Ovary Syndrome (PMOS), a condition affecting one in eight women, emphasizing the need for lifelong lifestyle changes and addressing common misconceptions.
New research suggests a link between prenatal exposure to 'forever chemicals' (PFAS) and the later development of polyendocrine metabolic ovarian syndrome (PMOS), formerly known as PCOS.
Polycystic Ovary Syndrome (PCOS) has been renamed Polyendocrine Metabolic Ovarian Syndrome (PMOS) to better reflect its understanding as a hormonal and metabolic disorder, as many women with the condition do not have ovarian cysts.
The medical condition Polycystic Ovary Syndrome (PCOS) has been renamed to Polycystic Metabolic Ovary Syndrome (PMOS), but women express skepticism that a name change alone will address their struggles.
This article highlights six early symptoms of Polycystic Ovary Syndrome (PCOS) that are frequently ignored, contributing to late diagnosis of the condition.
Polycystic Ovary Syndrome (PCOS) is receiving a new name, prompting discussions on how this change might lead to better treatment and care for patients.
Polycystic Ovary Syndrome (PCOS) is potentially being renamed to PMOS, and this article discusses what the new name could mean for the women affected by the condition.
An AIIMS doctor explains the significance of the renaming of Polycystic Ovary Syndrome (PCOS) to Polycystic Metabolic Ovary Syndrome (PMOS), marking a landmark shift in medical understanding.
Polycystic Ovary Syndrome (PCOS) has been officially renamed Polycystic Metabolic Ovarian Syndrome (PMOS) after a 14-year global effort, aiming to better reflect the condition's hormonal and metabolic nature and improve diagnoses.
Polycystic Ovary Syndrome (PCOS) has been given a new name, reportedly PMOS, following an "unprecedented" global effort to better reflect the condition's systemic nature beyond just ovarian symptoms. This change aims to offer new hope and understanding for millions of women affected.
Medical experts are advocating for a new name for Polycystic Ovary Syndrome (PCOS), explaining why this change is important for millions of women affected by the condition.
PMOS, a hormonal disorder formerly known as PCOS, affects approximately one in eight women but remains largely unknown. A new name and guidelines for patients are expected to improve care for this condition.
Hormonal imbalance can lead to weight gain, particularly around the abdomen, with conditions like menopause, PCOS, and hypothyroidism being contributing factors. Seeking medical advice for diagnosis and treatment is emphasized.
A discussion on the evolving understanding of Polycystic Ovary Syndrome (PCOS), suggesting it should be primarily understood as a metabolic health issue rather than solely a reproductive one.
A recent report indicates that the condition previously known as Polycystic Ovary Syndrome (PCOS) has been given a new name. This change comes about a century after surgeons first observed the characteristic ovarian cysts.
A complex hormonal condition, previously known as Polycystic Ovary Syndrome (PCOS), is now understood to influence ovulation, skin, weight, metabolism, and fertility. A new international name, polymetabolic ovarian polyendocrine syndrome, aims to better reflect its multifaceted nature.
Polycystic Ovary Syndrome (PCOS) has officially changed its name to Polyendocrine Metabolic Ovarian Syndrome (PMOS) in mid-May 2026. This change, published in The Lancet, follows years of research and appeals from international health organizations, aiming for faster diagnosis.
A German article discusses how women can recognize symptoms of endometriosis and PCOS, exploring broader topics like social media's influence on women's health and medical blind spots.
An article clarifies the differences between PMOS (Post-Menstrual Syndrome) and PCOS (Polycystic Ovary Syndrome), providing insights into women's health conditions.
Polycystic Ovary Syndrome (PCOS) is being renamed to Polycystic Metabolic Ovarian Syndrome (PMOS). This change aims to better reflect the condition's complex and broader health effects on women.
Polycystic Ovary Syndrome (PCOS) has been renamed to Polyendocrine Metabolic Ovarian Syndrome (PMOS) to more accurately reflect its broad health impacts, with doctors hoping the change will improve patient care globally.
Polycystic Ovary Syndrome (PCOS) has been officially renamed Polyendocrine Metabolic Ovarian Syndrome (PMOS) after more than a decade of discussion. This change is hoped to lead to earlier diagnosis and a more holistic approach to treatment for millions of affected women.
A global coalition of patients, doctors, and organizations has proposed a new name for Polycystic Ovary Syndrome (PCOS): 'Polymetabolic Polyendocrine Ovary Syndrome,' to better reflect its hormonal and metabolic impacts.
The Central Bureau of Investigation (CBI) has initiated a probe against former WAPCOS CMD RK Agrawal for alleged financial irregularities, including travel payments for his son, following approval from Union Jal Shakti minister CR Patil.
A young woman named Samanta recounts her eight-year struggle with Polycystic Ovary Syndrome (PCOS), describing feelings of being trapped in her body and facing medical indifference.
Experts and women living with Polycystic Ovary Syndrome (PCOS) argue that the condition's name is reductive and misleading, highlighting its wide-ranging health effects beyond just ovarian cysts.